WHATNEXT partner website Patient Worthy recently shared the results of a recent study, which found that Graves’ disease patients being treated with antithyroid therapies were at an increased risk of developing certain types of cancer, such as pancreatic cancer, biliary tract cancer, thyroid cancer, prostate cancer, and ovarian cancer.
Author James Moore writes:
At a mean follow-up time of 12.4 years, 9.7% of people in the control group received a cancer diagnosis while 16.5% of patients did. In multivariable analysis, Graves’ disease patients had a greater risk of developing the types of cancer previously mentioned. A further sensitivity analysis, which excluded the first follow-up year, continued to indicate that patients saw an elevated risk of cancer. The same was true after 5+ years of follow-up.
Check out the full article here.
Editor’s Note: Get Involved
Cancer doesn’t discriminate. WHATNEXT and its partners are interested in amplifying the voices of those from all identities and backgrounds. If you have a cancer journey to share, reach out here to learn more about how your voice can help spread awareness and inspire individuals from all walks of life.
biliary tract cancer ovarian cancer pancreatic cancer prostate cancer research thyroid cancer
Last modified: November 14, 2024
